Search

Your search keyword '"Vesole, David H."' showing total 537 results

Search Constraints

Start Over You searched for: Author "Vesole, David H." Remove constraint Author: "Vesole, David H." Language english Remove constraint Language: english
537 results on '"Vesole, David H."'

Search Results

2. Impact of second primary malignancy post–autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis

4. POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter Analysis

5. Post-ASCT consolidation with elotuzumab, lenalidomide, and dexamethasone or elotuzumab, pomalidomide, and dexamethasone in high-risk and ultra-high-risk multiple myeloma: a retrospective single-center study.

6. Venetoclax-based induction therapy for primary plasma cell leukemia with high BCL-2 expression.

10. Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group

11. KDIGO Controversies Conference on onco-nephrology: kidney disease in hematological malignancies and the burden of cancer after kidney transplantation

12. KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer

13. Negative Impact of Borderline Creatinine Concentration and Glomerular Filtration Rate at Baseline on the Outcome of Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplant

14. Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network 0102 Trial

15. Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT)

17. Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment—67 Patients Multicenter Analysis.

23. Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group

24. Allogeneic Transplantation for Relapsed Waldenström Macroglobulinemia and Lymphoplasmacytic Lymphoma

30. Recent Advancements and Future Directions in Frontline Treatment of Multiple Myeloma

31. Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control study

32. Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation

35. A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma

36. Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy

37. Restoring sensitivity to daratumumab with all-transretinoic acid in a patient with daratumumab-refractory multiple myeloma: A case report and review of the literature

38. Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients

39. Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients.

40. Initial Results of Dose Escalation of ISB 1342, a Novel CD3xCD38 Bispecific Antibody, in Patients with Relapsed / Refractory Multiple Myeloma (RRMM)

42. Salvage Second Hematopoietic Cell Transplantation in Myeloma

44. A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma

45. An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma

47. Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis

48. International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation

49. Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial

Catalog

Books, media, physical & digital resources